Financial Year |
March 31 2023 |
Monetary Funds |
1,419,105,594.23 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
330,027,923.59 |
Accounts Receivable |
515,476,553.08 |
Advances to Suppliers |
258,951,071.21 |
Other Receivables |
66,973,460.97 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
3,883,189,288.25 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
43,306,211.47 |
Total Current Assets |
6,665,545,006.39 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
8,715,589,204.07 |
Under-construction Projects |
140,493,451.45 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
679,690,719.76 |
R&D expenses |
-- |
Goodwill |
214,938,282.05 |
Long-Term Deferred and Prepaid Expenses |
4,567,149.14 |
Deferred Income Tax Assets |
27,789,619.04 |
Other Non-Current Assets |
87,523,555.22 |
Sub-Total of Non-Current Assets |
9,905,969,472.87 |
Total Assets |
16,571,514,479.26 |
Short-Term Loans |
2,579,507,350.01 |
Trading Financial liabilities |
212,593,253.26 |
Notes Payable |
665,118,298.58 |
Accounts Payable |
1,138,303,201.13 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
79,687,707.32 |
Taxes Payable |
121,093,154.89 |
Interest Payable |
-- |
Dividend Payable |
6,463,729.87 |
Other payables |
947,474,401.69 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,178,888,466.68 |
Other Current Liabilities |
287,655,311.62 |
Sub-Total of Current Liabilities |
7,460,102,285.47 |
Long-term Loans |
1,573,941,179.09 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
240,074,848.48 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
159,916,450.13 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
2,049,632,227.80 |
Total Liabilities |
9,509,734,513.27 |
Paid-In Capital(Or Share Stock) |
1,661,472,616.00 |
Capital Surplus |
4,687,799,232.44 |
Surplus Reserve |
16,570,647.81 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
627,605,938.17 |
Minority Stockholder's Interest |
49,977,694.63 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,011,802,271.36 |
Owner's Equity(Stockholder's Equity) |
7,061,779,965.99 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
16,571,514,479.26 |